Physiological Role for Casein Kinase 1 in Glutamatergic Synaptic Transmission

Overview

Journal J Neurosci

Specialty Neurology

Date 2005 Jul 15

PMID 16014721

Citations 36

Authors

Karima Chergui

Per Svenningsson

Paul Greengard

Affiliations

Soon will be listed here.

Abstract

Casein kinase 1 (CK1) is a highly conserved serine/threonine kinase, present in virtually all cell types, in which it phosphorylates a wide variety of substrates. So far, no role has been found for this ubiquitous protein kinase in the physiology of nerve cells. In the present study, we show that CK1 regulates fast synaptic transmission mediated by glutamate, the major excitatory neurotransmitter in the brain. Through the use of CK1 inhibitors, we present evidence that activation of CK1 decreases NMDA receptor activity in the striatum via a mechanism that involves activation by this kinase of protein phosphatase 1 and/or 2A and resultant increased dephosphorylation of NMDA receptors. Indeed, inhibition of CK1 increases NMDA-mediated EPSCs in medium spiny striatal neurons. This effect is associated with an increased phosphorylation of the NR1 and NR2B subunits of the NMDA receptor and is occluded by the phosphatase inhibitor okadaic acid. The mGluR1, but not mGluR5, subclass of metabotropic glutamate receptors uses CK1 to inhibit NMDA-mediated synaptic currents. These results provide the first evidence for a role of CK1 in the regulation of synaptic transmission in the brain.

Citing Articles

Citalopram exposure of hESCs during neuronal differentiation identifies dysregulated genes involved in neurodevelopment and depression.

Spildrejorde M, Leithaug M, Samara A, Aass H, Sharma A, Acharya G Front Cell Dev Biol. 2024; 12:1428538.

PMID: 39055655 PMC: 11269147. DOI: 10.3389/fcell.2024.1428538.

Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.

Loukil A, Ebright E, Uezu A, Gao Y, Soderling S, Goetz S bioRxiv. 2024; .

PMID: 38187761 PMC: 10769350. DOI: 10.1101/2023.12.20.572700.

Non-canonical interplay between glutamatergic NMDA and dopamine receptors shapes synaptogenesis.

Benac N, Ezequiel Saraceno G, Butler C, Kuga N, Nishimura Y, Yokoi T Nat Commun. 2024; 15(1):27.

PMID: 38167277 PMC: 10762086. DOI: 10.1038/s41467-023-44301-z.

Increased presynaptic excitability in a migraine with aura mutation.

Suryavanshi P, Sawant-Pokam P, Clair S, Brennan K Brain. 2023; 147(2):680-697.

PMID: 37831655 PMC: 10834252. DOI: 10.1093/brain/awad326.

Inhibition of casein kinase 1 δ/ε improves cognitive performance in adult C57BL/6J mice.

Mahoney H, Peterson E, Justin H, Gonzalez D, Cardona C, Stevanovic K Sci Rep. 2021; 11(1):4746.

PMID: 33637777 PMC: 7910436. DOI: 10.1038/s41598-021-83957-9.

References

Dingledine R, Borges K, Bowie D, Traynelis S . The glutamate receptor ion channels. Pharmacol Rev. 1999; 51(1):7-61. View

Lu W, Xiong Z, Lei S, Orser B, Dudek E, Browning M . G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci. 1999; 2(4):331-8. DOI: 10.1038/7243. View

Chergui K, Lacey M . Modulation by dopamine D1-like receptors of synaptic transmission and NMDA receptors in rat nucleus accumbens is attenuated by the protein kinase C inhibitor Ro 32-0432. Neuropharmacology. 1999; 38(2):223-31. DOI: 10.1016/s0028-3908(98)00187-7. View

WESTPHAL R, Tavalin S, Lin J, Alto N, Fraser I, Langeberg L . Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science. 1999; 285(5424):93-6. DOI: 10.1126/science.285.5424.93. View

Calabresi P, Centonze D, Pisani A, Bernardi G . Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease. Exp Neurol. 1999; 158(1):97-108. DOI: 10.1006/exnr.1999.7092. View

Ghoshal N, Smiley J, DeMaggio A, Hoekstra M, Cochran E, Binder L . A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease. Am J Pathol. 1999; 155(4):1163-72. PMC: 1867028. DOI: 10.1016/S0002-9440(10)65219-4. View

Peters J, McKay R, McKay J, Graff J . Casein kinase I transduces Wnt signals. Nature. 1999; 401(6751):345-50. DOI: 10.1038/43830. View

Herzig S, Neumann J . Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol Rev. 2000; 80(1):173-210. DOI: 10.1152/physrev.2000.80.1.173. View

Fagni L, Chavis P, Ango F, Bockaert J . Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons. Trends Neurosci. 2000; 23(2):80-8. DOI: 10.1016/s0166-2236(99)01492-7. View

10.

Chergui K, Bouron A, Normand E, Mulle C . Functional GluR6 kainate receptors in the striatum: indirect downregulation of synaptic transmission. J Neurosci. 2000; 20(6):2175-82. PMC: 6772511. View

11.

Mashhoon N, DeMaggio A, Tereshko V, Bergmeier S, Egli M, Hoekstra M . Crystal structure of a conformation-selective casein kinase-1 inhibitor. J Biol Chem. 2000; 275(26):20052-60. DOI: 10.1074/jbc.M001713200. View

12.

Yasojima K, Kuret J, DeMaggio A, McGeer E, McGeer P . Casein kinase 1 delta mRNA is upregulated in Alzheimer disease brain. Brain Res. 2000; 865(1):116-20. DOI: 10.1016/s0006-8993(00)02200-9. View

13.

Takano A, Shimizu K, Kani S, Buijs R, Okada M, Nagai K . Cloning and characterization of rat casein kinase 1epsilon. FEBS Lett. 2000; 477(1-2):106-12. DOI: 10.1016/s0014-5793(00)01755-5. View

14.

Schwab C, DeMaggio A, Ghoshal N, Binder L, Kuret J, McGeer P . Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases. Neurobiol Aging. 2000; 21(4):503-10. DOI: 10.1016/s0197-4580(00)00110-x. View

15.

DAVIES S, Reddy H, Caivano M, Cohen P . Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000; 351(Pt 1):95-105. PMC: 1221339. DOI: 10.1042/0264-6021:3510095. View

16.

Whitmore D, Cermakian N, Crosio C, Foulkes N, Pando M, Travnickova Z . A clockwork organ. Biol Chem. 2000; 381(9-10):793-800. DOI: 10.1515/BC.2000.102. View

17.

Behrend L, Milne D, Stoter M, Deppert W, Campbell L, Meek D . IC261, a specific inhibitor of the protein kinases casein kinase 1-delta and -epsilon, triggers the mitotic checkpoint and induces p53-dependent postmitotic effects. Oncogene. 2000; 19(47):5303-13. DOI: 10.1038/sj.onc.1203939. View

18.

Scannevin R, Huganir R . Postsynaptic organization and regulation of excitatory synapses. Nat Rev Neurosci. 2001; 1(2):133-41. DOI: 10.1038/35039075. View

19.

Brickley S, Farrant M . NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol. 2001; 11(3):327-35. DOI: 10.1016/s0959-4388(00)00215-4. View

20.

Battaglia G, Bruno V, Pisani A, Centonze D, Catania M, Calabresi P . Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Mol Cell Neurosci. 2001; 17(6):1071-83. DOI: 10.1006/mcne.2001.0992. View